Integer Holdings Corporation (ITGR)
USD 125.66
(0.06%)
USD 125.66
(0.06%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.41 Billion USD | 2.64% |
| 2022 | 1.37 Billion USD | 12.17% |
| 2021 | 1.22 Billion USD | 11.51% |
| 2020 | 1.1 Billion USD | -8.31% |
| 2019 | 1.2 Billion USD | -5.18% |
| 2018 | 1.26 Billion USD | -35.23% |
| 2017 | 1.95 Billion USD | -7.23% |
| 2016 | 2.1 Billion USD | -1.14% |
| 2015 | 2.13 Billion USD | 522.07% |
| 2014 | 342.64 Million USD | -1.72% |
| 2013 | 348.64 Million USD | -14.76% |
| 2012 | 409.01 Million USD | -1.22% |
| 2011 | 414.06 Million USD | 18.25% |
| 2010 | 350.14 Million USD | -22.33% |
| 2009 | 450.81 Million USD | -9.51% |
| 2008 | 498.17 Million USD | 46.02% |
| 2007 | 341.18 Million USD | 37.5% |
| 2006 | 248.13 Million USD | 1.57% |
| 2005 | 244.3 Million USD | 9.18% |
| 2004 | 223.76 Million USD | 10.28% |
| 2003 | 202.9 Million USD | 92.53% |
| 2002 | 105.38 Million USD | 11.31% |
| 2001 | 94.67 Million USD | 106.66% |
| 2000 | 45.81 Million USD | -68.05% |
| 1999 | 143.37 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.57 Billion USD | -1.16% |
| 2024 Q1 | 1.59 Billion USD | 12.58% |
| 2024 Q3 | 1.54 Billion USD | -1.66% |
| 2023 Q3 | 1.37 Billion USD | -2.8% |
| 2023 Q1 | 1.45 Billion USD | 5.71% |
| 2023 FY | 1.41 Billion USD | 2.64% |
| 2023 Q2 | 1.41 Billion USD | -2.74% |
| 2023 Q4 | 1.41 Billion USD | 2.71% |
| 2022 Q4 | 1.37 Billion USD | -0.47% |
| 2022 Q1 | 1.24 Billion USD | 1.32% |
| 2022 Q2 | 1.39 Billion USD | 12.14% |
| 2022 Q3 | 1.38 Billion USD | -0.81% |
| 2022 FY | 1.37 Billion USD | 12.17% |
| 2021 Q3 | 1.01 Billion USD | -2.75% |
| 2021 Q2 | 1.04 Billion USD | -1.98% |
| 2021 FY | 1.22 Billion USD | 11.51% |
| 2021 Q1 | 1.06 Billion USD | -3.2% |
| 2021 Q4 | 1.22 Billion USD | 20.83% |
| 2020 Q4 | 1.1 Billion USD | -9.47% |
| 2020 Q1 | 1.23 Billion USD | 2.77% |
| 2020 Q2 | 1.34 Billion USD | 8.77% |
| 2020 Q3 | 1.21 Billion USD | -9.39% |
| 2020 FY | 1.1 Billion USD | -8.31% |
| 2019 FY | 1.2 Billion USD | -5.18% |
| 2019 Q4 | 1.2 Billion USD | -2.41% |
| 2019 Q1 | 1.29 Billion USD | 1.98% |
| 2019 Q3 | 1.23 Billion USD | -2.51% |
| 2019 Q2 | 1.26 Billion USD | -2.27% |
| 2018 Q3 | 1.31 Billion USD | -30.47% |
| 2018 FY | 1.26 Billion USD | -35.23% |
| 2018 Q4 | 1.26 Billion USD | -3.83% |
| 2018 Q2 | 1.89 Billion USD | -1.71% |
| 2018 Q1 | 1.92 Billion USD | -1.45% |
| 2017 Q4 | 1.95 Billion USD | -3.7% |
| 2017 Q3 | 2.03 Billion USD | -1.54% |
| 2017 Q2 | 2.06 Billion USD | -1.64% |
| 2017 FY | 1.95 Billion USD | -7.23% |
| 2017 Q1 | 2.09 Billion USD | -0.53% |
| 2016 FY | 2.1 Billion USD | -1.14% |
| 2016 Q2 | 2.17 Billion USD | -0.07% |
| 2016 Q1 | 2.18 Billion USD | 2.3% |
| 2016 Q4 | 2.1 Billion USD | -1.74% |
| 2016 Q3 | 2.14 Billion USD | -1.58% |
| 2015 Q1 | 318.25 Million USD | -7.12% |
| 2015 Q2 | 324.52 Million USD | 1.97% |
| 2015 FY | 2.13 Billion USD | 522.07% |
| 2015 Q3 | 336.65 Million USD | 3.74% |
| 2015 Q4 | 2.13 Billion USD | 533.15% |
| 2014 FY | 342.64 Million USD | -1.72% |
| 2014 Q3 | 334.22 Million USD | 1.8% |
| 2014 Q4 | 342.64 Million USD | 2.52% |
| 2014 Q1 | 323.55 Million USD | -7.2% |
| 2014 Q2 | 328.3 Million USD | 1.47% |
| 2013 Q2 | 394.17 Million USD | -0.35% |
| 2013 Q1 | 395.54 Million USD | -3.29% |
| 2013 Q3 | 360.25 Million USD | -8.61% |
| 2013 Q4 | 348.64 Million USD | -3.22% |
| 2013 FY | 348.64 Million USD | -14.76% |
| 2012 Q3 | 411.26 Million USD | 2.37% |
| 2012 Q1 | 403.61 Million USD | -2.52% |
| 2012 FY | 409.01 Million USD | -1.22% |
| 2012 Q4 | 409.01 Million USD | -0.55% |
| 2012 Q2 | 401.74 Million USD | -0.46% |
| 2011 FY | 414.06 Million USD | 18.25% |
| 2011 Q4 | 414.06 Million USD | 19.01% |
| 2011 Q3 | 347.91 Million USD | -2.24% |
| 2011 Q2 | 355.89 Million USD | -2.62% |
| 2011 Q1 | 365.45 Million USD | 4.37% |
| 2010 FY | 350.14 Million USD | -22.33% |
| 2010 Q1 | 451.6 Million USD | 0.17% |
| 2010 Q4 | 350.14 Million USD | -14.67% |
| 2010 Q3 | 410.36 Million USD | -4.73% |
| 2010 Q2 | 430.76 Million USD | -4.62% |
| 2009 FY | 450.81 Million USD | -9.51% |
| 2009 Q2 | 442.6 Million USD | -3.64% |
| 2009 Q3 | 467.41 Million USD | 5.61% |
| 2009 Q4 | 450.81 Million USD | -3.55% |
| 2009 Q1 | 459.33 Million USD | -7.8% |
| 2008 Q2 | 491.14 Million USD | 1.83% |
| 2008 Q1 | 482.33 Million USD | 41.37% |
| 2008 FY | 498.17 Million USD | 46.02% |
| 2008 Q4 | 498.17 Million USD | 1.73% |
| 2008 Q3 | 489.72 Million USD | -0.29% |
| 2007 Q1 | 317.13 Million USD | 27.81% |
| 2007 FY | 341.18 Million USD | 37.5% |
| 2007 Q4 | 341.18 Million USD | 4.59% |
| 2007 Q3 | 326.19 Million USD | 1.49% |
| 2007 Q2 | 321.39 Million USD | 1.34% |
| 2006 Q1 | 236.98 Million USD | -3.0% |
| 2006 FY | 248.13 Million USD | 1.57% |
| 2006 Q3 | 241.81 Million USD | -0.08% |
| 2006 Q4 | 248.13 Million USD | 2.61% |
| 2006 Q2 | 241.99 Million USD | 2.11% |
| 2005 FY | 244.3 Million USD | 9.18% |
| 2005 Q1 | 220.13 Million USD | -1.62% |
| 2005 Q2 | 226.56 Million USD | 2.92% |
| 2005 Q3 | 236.65 Million USD | 4.45% |
| 2005 Q4 | 244.3 Million USD | 3.23% |
| 2004 FY | 223.76 Million USD | 10.28% |
| 2004 Q4 | 223.76 Million USD | 4.96% |
| 2004 Q3 | 213.19 Million USD | 1.11% |
| 2004 Q2 | 210.85 Million USD | 1.71% |
| 2004 Q1 | 207.3 Million USD | 2.17% |
| 2003 Q1 | 95.01 Million USD | -9.84% |
| 2003 Q3 | 198.78 Million USD | 3.61% |
| 2003 Q2 | 191.85 Million USD | 101.92% |
| 2003 Q4 | 202.9 Million USD | 2.07% |
| 2003 FY | 202.9 Million USD | 92.53% |
| 2002 FY | 105.38 Million USD | 11.31% |
| 2002 Q3 | 104.82 Million USD | 21.52% |
| 2002 Q1 | 87.89 Million USD | -7.16% |
| 2002 Q2 | 86.26 Million USD | -1.86% |
| 2002 Q4 | 105.38 Million USD | 0.54% |
| 2001 FY | 94.67 Million USD | 106.66% |
| 2001 Q1 | 48.63 Million USD | 6.16% |
| 2001 Q2 | 100 Million USD | 105.61% |
| 2001 Q3 | 100.84 Million USD | 0.84% |
| 2001 Q4 | 94.67 Million USD | -6.12% |
| 2000 FY | 45.81 Million USD | -68.05% |
| 2000 Q4 | 45.81 Million USD | -67.07% |
| 2000 Q3 | 139.1 Million USD | 0.0% |
| 1999 FY | 143.37 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Abbott Laboratories | 34.38 Billion USD | 95.89% |
| Allurion Technologies Inc. | 142.19 Million USD | -893.835% |
| Artivion, Inc. | 510.61 Million USD | -176.768% |
| Avanos Medical, Inc. | 456.1 Million USD | -209.849% |
| Butterfly Network, Inc. | 84.22 Million USD | -1577.994% |
| Butterfly Network, Inc. | 84.22 Million USD | -1577.994% |
| Bio-Rad Laboratories, Inc. | 3.55 Billion USD | 60.28% |
| Boston Scientific Corporation | 15.6 Billion USD | 90.944% |
| CONMED Corporation | 1.46 Billion USD | 3.587% |
| Edwards Lifesciences Corporation | 2.64 Billion USD | 46.546% |
| Paragon 28, Inc. | 162.95 Million USD | -767.231% |
| Glaukos Corporation | 478.64 Million USD | -195.253% |
| Globus Medical, Inc. | 1.08 Billion USD | -29.877% |
| Inspire Medical Systems, Inc. | 104.29 Million USD | -1254.999% |
| Medtronic plc | 39.56 Billion USD | 96.428% |
| Myomo, Inc. | 5.59 Million USD | -25171.243% |
| Nevro Corp. | 330.31 Million USD | -327.846% |
| Owlet, Inc. | 73.79 Million USD | -1814.962% |
| Penumbra, Inc. | 377.36 Million USD | -274.502% |
| Vicarious Surgical Inc. | 21.89 Million USD | -6354.547% |
| Smith & Nephew plc | 4.77 Billion USD | 70.373% |
| STERIS plc | 4.74 Billion USD | 70.238% |
| Stryker Corporation | 21.31 Billion USD | 93.371% |
| Vapotherm, Inc. | 132.95 Million USD | -962.965% |
| Zimmer Biomet Holdings, Inc. | 9 Billion USD | 84.313% |